Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy

NCT03025399 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

384

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Non-proliferative Retinopathy
Type2 Diabetes

Interventions

DRUG: Tangwang prescription
DRUG: Placebo

Sponsor

Fengmei Lian

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]